BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20531006)

  • 1. High Frequency of Aneuploidy Defines Ulcerative Colitis-Associated Carcinomas: A Prognostic Comparison to Sporadic Colorectal Carcinomas.
    Gerling M; Meyer KF; Fuchs K; Igl BW; Fritzsche B; Ziegler A; Bader F; Kujath P; Schimmelpenning H; Bruch HP; Roblick UJ; Habermann JK
    Ann Surg; 2010 Jul; 252(1):74-83. PubMed ID: 20531006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aneuploidy characterizes adjacent non-malignant mucosa of ulcerative colitis-associated but not sporadic colorectal carcinomas: a matched-pair analysis.
    Meyer KF; Nause SL; Freitag-Wolf S; Krüger S; Bruch HP; Roblick UJ; Habermann JK
    Scand J Gastroenterol; 2013 Jun; 48(6):679-87. PubMed ID: 23544594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aneuploidy-associated gene expression signatures characterize malignant transformation in ulcerative colitis.
    Gerling M; Nousiainen K; Hautaniemi S; Krüger S; Fritzsche B; Homann N; Bruch HP; Auer G; Roblick UJ; Ried T; Habermann JK
    Inflamm Bowel Dis; 2013; 19(4):691-703. PubMed ID: 23455720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of Ulcerative Colitis-Associated Colorectal Carcinoma Compared to Sporadic Colorectal Carcinoma: A Matched Pair Analysis.
    Leowardi C; Schneider ML; Hinz U; Harnoss JM; Tarantino I; Lasitschka F; Ulrich A; Büchler MW; Kadmon M
    Ann Surg Oncol; 2016 Mar; 23(3):870-6. PubMed ID: 26467453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant methylation of DAPK in long-standing ulcerative colitis and ulcerative colitis-associated carcinoma.
    Kuester D; Guenther T; Biesold S; Hartmann A; Bataille F; Ruemmele P; Peters B; Meyer F; Schubert D; Bohr UR; Malfertheiner P; Lippert H; Silver AR; Roessner A; Schneider-Stock R
    Pathol Res Pract; 2010 Sep; 206(9):616-24. PubMed ID: 20630662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of DNA ploidy status in patients with rectal cancer.
    Berczi C; Bocsi J; Bartha I; Math J; Balazs G
    Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Feasibility of DNA analysis for prognostic evaluations of colorectal cancer using touch preparations and image cytometry].
    Ando H; Sawada T; Saito Y; Sunouchi K; Masaki T; Suzuki K; Hamaguchi M; Sameshima S; Shinozaki M; Tsuno N
    Gan To Kagaku Ryoho; 1994 May; 21 Suppl 1():89-94. PubMed ID: 8203937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic inflammatory bowel disease and cancer.
    Pohl C; Hombach A; Kruis W
    Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
    Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL
    Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
    Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
    Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [DNA ploidy and dysplasia in ulcerative colitis--interim analysis of a prospective study].
    Porschen R; Molsberger G; Reis C; Borchard F; Reis HE; Eckardt VF; Purrmann J; Hengels KJ; Strohmeyer G
    Z Gastroenterol; 1992 Dec; 30(12):857-62. PubMed ID: 1481552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Flow cytometric analysis in colorectal cancer with hepatic metastases and its relationship to metastatic characteristics and prognosis].
    Yamaguchi A; Ishida T; Nishimura G; Kanno M; Kosaka T; Yonemura Y; Miyazaki I
    Nihon Geka Gakkai Zasshi; 1990 Oct; 91(10):1591-5. PubMed ID: 2263242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA content and its relationship with pathology and prognosis of colorectal carcinoma.
    Jiang B; Liu CG; Wang MW; Zhao DH; Li Y; Ji XL
    Chin Med J (Engl); 1992 Mar; 105(3):241-6. PubMed ID: 1395845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of heterogeneity and of multiple site sampling in the prospective determination of deoxyribonucleic acid flow cytometry.
    Stipa S; Danesi DT; Modini C; Cicconetti F; Mauro F; Schillaci A; Mecozzi A; Nicolanti V; Stipa F; Mancini M
    Surg Gynecol Obstet; 1993 May; 176(5):427-34. PubMed ID: 8386859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies in longstanding ulcerative colitis with special reference to malignant transformation of the colorectal mucosa.
    Löfberg R
    Acta Chir Scand Suppl; 1989; 552():1-45. PubMed ID: 2800882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retrospective flow-cytometric analysis of the DNA content in colorectal carcinomas and the test of the prognostic significance of DNA ploidy].
    Baretton G; Gille J; Oevermann E; Löhrs U
    Verh Dtsch Ges Pathol; 1990; 74():233-7. PubMed ID: 1708591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer in colonic Crohn's disease--high frequency of DNA-aneuploidy.
    Sjöqvist U; Befrits R; Söderlund S; Ost A; Karlén P; Tribukait B; Rubio C; Rutgeerts P; Geboes K; Löfberg R
    Anticancer Res; 2005; 25(6C):4393-7. PubMed ID: 16334114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric analysis of DNA abnormalities in colorectal carcinomas.
    Bocquillon PG; Daver A; Page M; Dalifard I; Chassevent A; Cellier P; Bertrand G; Larra F; George P; Chabrun B
    Bull Cancer; 1989; 76(3):291-300. PubMed ID: 2736315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ulcerative colitis and colorectal carcinoma: DNA-profile, laminin-5 gamma2 chain and cyclin A expression as early markers for risk assessment.
    Habermann J; Lenander C; Roblick UJ; Krüger S; Ludwig D; Alaiya A; Freitag S; Dümbgen L; Bruch HP; Stange E; Salo S; Tryggvason K; Auer G; Schimmelpenning H
    Scand J Gastroenterol; 2001 Jul; 36(7):751-8. PubMed ID: 11444475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of prognostic parameters in colorectal carcinoma. II. Ploidy determination with flow cytometry].
    Lanza G; Maestri I; Dubini A; Gafà R
    Pathologica; 1994 Feb; 86(1):30-42. PubMed ID: 8072799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.